US · Healthcare · Medical Devices
EPS came in at 0.10 against a street estimate of -0.27 — a beat of 137.0%.
Analysts rate LENSAR Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $11.50.
| Fund | Stake |
|---|---|
| Brandes Investment Partners & Co | 8.75% |
| BlackRock Inc | 5.12% |
| Vanguard Capital Management, LLC | 3.18% |
| Geode Capital Management, LLC | 1.87% |
| Css LLC | 1.33% |
| Dimensional Fund Advisors, Inc. | 1.23% |
| Kerrisdale Advisers, LLC | 1.13% |
| State Street Corp | 1.10% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for LENSAR Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.